Superworth4D Molecular Therapeutics shares outstanding FDMT
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 70.3M
- On a year earlier
- +25.6%
- more shares
4D Molecular Therapeutics had 70.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 25.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 63.9M | +15% |
| FY2024 | 55.6M | +30% |
| FY2023 | 42.8M | +32% |
| FY2022 | 32.5M | +7% |
| FY2021 | 30.4M | +200% |
| FY2020 | 10.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 70.3M | +26% | |
| Q1 FY26 | 68.1M | +22% | |
| Q4 FY25 | 63.9M | +15% | |
| Q3 FY25 | 56.1M | +1% | |
| Q2 FY25 | 55.9M | +1% | |
| Q1 FY25 | 55.7M | +13% | |
| Q4 FY24 | 55.6M | +30% | |
| Q3 FY24 | 55.6M | +31% | |
| Q2 FY24 | 55.3M | +44% | |
| Q1 FY24 | 49.3M | +51% | |
| Q4 FY23 | 42.8M | +32% | |
| Q3 FY23 | 42.3M | +30% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on 4D Molecular Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.